Authors: Urbanska-Rys, H Wierzbowska, A Stepien, H Robak, T

Citation: H. Urbanska-rys et al., Relationship between circulating interleukin-10 (IL-10) with interleukin-6(IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 receptor (sIL-6R) in patients with multiple myeloma, EUR CYTOKIN, 11(3), 2000, pp. 443-451

Authors: Robak, T Gora-Tybor, J Urbanska-Rys, H Krykowski, E

Citation: T. Robak et al., Combination regimen of 2-chlorodeoxyadenosine (cladribine), mitoxantrone and dexamethasone (CMD) in the treatment of refractory and recurrent low grade non-Hodgkin's lymphoma, LEUK LYMPH, 32(3-4), 1999, pp. 359-363

Authors: Robak, T Blonski, JZ Urbanska-Rys, H Blasinska-Morawiec, M Skotnicki, AB

Citation: T. Robak et al., 2-chlorodeoxyadenosine (cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger, LEUKEMIA, 13(4), 1999, pp. 518-523

Authors: Wierzbowska, A Urbanska-Rys, H Robak, T

Citation: A. Wierzbowska et al., Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma, BR J HAEM, 105(2), 1999, pp. 412-419